Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 19  •  10:23AM ET
100.98
Dollar change
+0.18
Percentage change
0.18
%
IndexS&P 500 P/E27.26 EPS (ttm)3.70 Insider Own0.09% Shs Outstand1.28B Perf Week5.40%
Market Cap129.52B Forward P/E16.54 EPS next Y6.11 Insider Trans-0.31% Shs Float1.28B Perf Month5.37%
Enterprise Value150.25B PEG4.53 EPS next Q1.34 Inst Own86.95% Short Float1.13% Perf Quarter10.84%
Income4.76B P/S3.73 EPS this Y2.71% Inst Trans1.15% Short Ratio2.01 Perf Half Y19.63%
Sales34.76B P/B2.70 EPS next Y8.30% ROA5.16% Short Interest14.43M Perf YTD26.41%
Book/sh37.36 P/C15.95 EPS next 5Y6.02% ROE9.72% 52W High102.48 -1.46% Perf Year15.37%
Cash/sh6.33 P/FCF24.88 EPS past 3/5Y-1.03% 0.39% ROIC6.43% 52W Low79.29 27.35% Perf 3Y21.81%
Dividend Est.2.84 (2.81%) EV/EBITDA15.78 Sales past 3/5Y1.91% 3.01% Gross Margin67.90% Volatility1.97% 1.80% Perf 5Y-7.87%
Dividend TTM2.82 (2.79%) EV/Sales4.32 EPS Y/Y TTM22.08% Oper. Margin18.72% ATR (14)2.00 Perf 10Y32.76%
Dividend Ex-DateSep 26, 2025 Quick Ratio1.50 Sales Y/Y TTM5.34% Profit Margin13.71% RSI (14)75.01 Recom2.09
Dividend Gr. 3/5Y3.57% 5.33% Current Ratio2.01 EPS Q/Q8.42% SMA207.66% Beta0.68 Target Price108.93
Payout77.47% Debt/Eq0.60 Sales Q/Q6.64% SMA506.51% Rel Volume2.25 Prev Close100.80
Employees95000 LT Debt/Eq0.55 EarningsNov 18 BMO SMA20012.08% Avg Volume7.16M Price100.98
IPONov 21, 1977 Option/ShortYes / Yes EPS/Sales Surpr.3.49% 1.06% Trades Volume2,886,773 Change0.18%
Date Action Analyst Rating Change Price Target Change
TodayUpgrade Goldman Sell → Neutral $111
Jun-30-25Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25Initiated Leerink Partners Outperform $110
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Aug-21-24Reiterated Oppenheimer Perform $92 → $94
Aug-15-24Upgrade UBS Sell → Neutral $76 → $90
Aug-14-24Downgrade Stifel Buy → Hold $100 → $85
May-30-24Initiated Goldman Sell $83
Jul-19-23Initiated Robert W. Baird Neutral $90
Today 09:44AM
09:07AM
08:02AM
07:44AM
07:25AM
07:05AM Loading…
07:05AM
06:16AM
04:25AM
03:27AM
Nov-18-25 06:25PM
05:03PM
04:21PM
04:13PM
04:09PM
04:08PM
02:10PM Loading…
02:10PM
02:02PM
01:29PM
12:08PM
12:07PM
09:31AM
09:30AM
09:02AM
08:03AM
07:55AM
07:44AM
07:24AM
07:10AM
07:01AM
06:52AM
06:45AM Loading…
06:45AM
03:30AM
Nov-17-25 07:00PM
05:06PM
10:00AM
07:00AM
03:20AM
Nov-16-25 08:51AM
07:45AM
04:35AM
Nov-14-25 07:00PM
04:00PM
01:48PM
Nov-13-25 05:30PM
09:15AM
Nov-12-25 07:54AM
06:53AM
Nov-11-25 09:45AM
Nov-10-25 05:10PM
07:47AM
Nov-07-25 05:45PM
06:40AM
Nov-05-25 05:43PM
05:20PM
09:20AM
05:10AM
Nov-04-25 06:45AM
05:15AM
Oct-30-25 08:38AM
Oct-29-25 05:50PM
07:12AM
Oct-28-25 06:36PM
06:49AM
Oct-27-25 11:14AM
08:40AM
08:00AM
Oct-26-25 05:24PM
04:39AM
04:00AM
Oct-23-25 05:50PM
03:43AM
Oct-20-25 09:32AM
08:45AM
06:30AM
Oct-16-25 01:02PM
07:26AM
04:25AM
01:55AM
Oct-15-25 05:50PM
12:20PM
09:50AM
08:05AM
Oct-14-25 09:40AM
08:35AM
Oct-13-25 07:15PM
08:20AM
Oct-09-25 05:50PM
10:10AM
Oct-08-25 07:00AM
Oct-04-25 08:01AM
Oct-03-25 05:50PM
05:54AM
Oct-02-25 08:00AM
07:06AM
04:37AM
Oct-01-25 10:13AM
Sep-29-25 01:26PM
09:50AM
08:09AM
Sep-26-25 11:57AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIIL HARRY SKIPEVP & President CardiovascularSep 03 '25Sale91.588,605788,04835,615Sep 05 04:18 PM
KIIL HARRY SKIPOfficerSep 03 '25Proposed Sale91.588,605788,049Sep 03 03:23 PM
Jellison William RDirectorAug 22 '25Buy92.732,500231,8252,500Aug 25 05:18 PM
Jellison William RDirectorAug 25 '25Buy92.372,500230,9255,000Aug 25 05:18 PM
Walter Matthew R.SVP, Chief HR OfficerAug 01 '25Option Exercise23.913,14275,11432,804Aug 04 04:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 01 '25Option Exercise0.0015,249066,531Aug 04 04:20 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 01 '25Option Exercise0.0011,328083,071Aug 04 04:19 PM
Martha GeoffreyChairman and CEOAug 01 '25Option Exercise32.2198,3243,166,800284,923Aug 04 04:18 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasAug 01 '25Option Exercise25.249,661243,82857,628Aug 04 04:17 PM
KIIL HARRY SKIPEVP & President CardiovascularAug 01 '25Option Exercise0.0010,457051,775Aug 04 04:16 PM
Blomquist Denise L.Chief Accounting OfficerAug 01 '25Option Exercise32.2251816,69212,671Aug 04 04:15 PM
Salmon SeanOfficerJun 06 '25Proposed Sale86.8118,3781,595,469Jun 06 02:43 PM
Walter Matthew R.SVP, Chief HR OfficerJan 27 '25Option Exercise74.841,337100,06126,997Jan 28 05:10 PM
Marinaro MichaelEVP & President, Surgical OUJan 27 '25Option Exercise74.842,345175,50043,323Jan 28 05:09 PM
Martha GeoffreyChairman and CEOJan 27 '25Option Exercise74.8434,7412,600,016216,954Jan 28 05:07 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Option Exercise78.0012,437970,08653,416Jan 27 05:35 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Sale90.0012,4371,119,33040,979Jan 27 05:35 PM
Wall Brett A.OfficerJan 24 '25Proposed Sale90.0012,4371,119,330Jan 24 02:34 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Option Exercise74.846,850512,65450,558Jan 10 04:48 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Sale80.419,850792,03840,708Jan 10 04:48 PM
Wall Brett A.OfficerJan 08 '25Proposed Sale80.419,850792,038Jan 08 09:52 AM